Ignite Creation Date:
2024-05-05 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00126672
Status:
COMPLETED
Last Update Posted:
2022-04-25
First Post:
2005-08-02
Brief Title:
RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute
Organization Data
Organization:
Dana-Farber Cancer Institute
Class:
OTHER
Study ID:
04-298
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Dana-Farber Cancer Institute
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Tuberous Sclerosis Alliance | OTHER |
| National Cancer Institute NCI | NIH |
| Wyeth is now a wholly owned subsidiary of Pfizer | INDUSTRY |